Next Post

Mindmed Announces Voting Results for Annual General and Special Meeting

[ad_1] NEW YORK, June 1, 2022 /PRNewswire/ — Thoughts Medication (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), announces the voting success of the Company’s once-a-year general and specific assembly of shareholders held on June 1, 2022 (the “Conference”). Election of Administrators The five nominees of administration have […]